EUVIMEDEUVIMED entdecken
Crossref

Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers

Edoardo Beatrici, Marco Paciotti, David-Dan Nguyen, Dejan K Filipas, Zhiyu Qian, Giovanni Lughezzani, Danesha Daniels, Stuart R Lipsitz, Adam S Kibel, Alexander P Cole, Quoc-Dien Trinh iD

Cancer · 2024

DOI: 10.1002/cncr.35328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Edoardo Beatrici und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts,…. Hauptthemen laut MEDLINE: Healthcare Disparities, Prostatic Neoplasms, Colonic Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: American College of Surgeons.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to quantify disparities in cancer treatment delivery between minority‐serving hospitals (MSHs) and non‐MSHs for breast, prostate, nonsmall cell lung, and colon cancers from 2010 to 2019 and to estimate the impact of improving care at MSHs on national disparities.

Methods

Data from the National Cancer Database (2010–2019) identified patients who were eligible for definitive treatments for the specified cancers. Hospitals in the top decile by minority patient proportion were classified as MSHs. Multivariable logistic regression adjusted for patient and hospital characteristics compared the odds of receiving definitive treatment at MSHs versus non‐MSHs. A simulation was used to estimate the increase in patients receiving definitive treatment if MSH care matched the levels of non‐MSH care.

Results

Of 2,927,191 patients from 1330 hospitals, 9.3% were treated at MSHs. MSHs had significant lower odds of delivering definitive therapy across all cancer types (adjusted odds ratio: breast cancer, 0.83; prostate cancer, 0.69; nonsmall cell lung cancer, 0.73; colon cancer, 0.81). No site of care–race interaction was significant for any of the cancers ( p > .05). Equalizing treatment rates at MSHs could result in 5719 additional patients receiving definitive treatment over 10 years.

Conclusions

The current findings underscore systemic disparities in definitive cancer treatment delivery between MSHs and non‐MSHs for breast, prostate, nonsmall cell lung, and colon cancers. Although targeted improvements at MSHs represent a critical step toward equity, this study highlights the need for integrated, system‐wide efforts to address the multifaceted nature of racial and ethnic health disparities. Enhancing care at MSHs could serve as a pivotal strategy in a broader initiative to achieve health care equity for all.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Healthcare DisparitiesProstatic NeoplasmsColonic NeoplasmsBreast NeoplasmsLung NeoplasmsHospitalsHumansMaleFemaleMiddle AgedAgedUnited StatesMinority Groups

Stichwörter der Autor:innen

breast cancercolon cancerlung cancerminority populationsminority‐serving hospitalsprostate cancertreatment

Autor:innen und Institutionen

  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Department of Urology, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Division of Urology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID-Profile: Quoc-Dien Trinh

Förderung

  • American College of Surgeons

Zitieren

APA

Beatrici, E., Paciotti, M., Nguyen, D. D., Filipas, D. K., Qian, Z., Lughezzani, G., Daniels, D., Lipsitz, S. R., Kibel, A. S., Cole, A. P., & Trinh, Q. D. (2024). Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers. Cancer. https://doi.org/10.1002/cncr.35328

Vancouver

Beatrici E, Paciotti M, Nguyen DD, Filipas DK, Qian Z, Lughezzani G, et al. Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers. Cancer. 2024. doi:10.1002/cncr.35328

BibTeX
@article{Beatrici2024,
  author = {Beatrici, Edoardo and Paciotti, Marco and Nguyen, David-Dan and Filipas, Dejan K and Qian, Zhiyu and Lughezzani, Giovanni and Daniels, Danesha and Lipsitz, Stuart R and Kibel, Adam S and Cole, Alexander P and Trinh, Quoc-Dien},
  title = {Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35328}
}
Kostenlos starten →